Clinico-epidemiological study of pityriasis rosea in children
Abstract
Introduction: Pityriasis Rosea (PR) is an acute self limiting disorder, thought to represent a viral exanthema. In majority of cases, the first manifestation is “herald patch” or “mother patch” followed by secondary eruptions. The secondary eruptions appears in crops at an interval of one to two weeks following appearance of herald patch and run parallel to theline of skin cleavage, and mostly appears on the trunk and proximal portion of extremities.
Method: A prospective cohort study on the clinico-epidemiological pattern of PR in participants of age group below 15 years was performed over a period of three years.
Results: a total 782 patients with clinical diagnosis of PR were treated at our OPD, among them 73 patients fulfilled the study criteria and hence were analyzed and reported here. Out of these 39 (53.4%) were male and 34(46.6%) were female child. Frequency of PR was highest among age group 11 to 15 years (57.5%), followed by 35.6% in age group 5 to 10 years and was lowest among group below 5 years of age (6.9%). Pruritus was found in 53(72.6%) patients. Seasonal variation was evident, with highest incidence in summer season, followed by winter and rainy season.
Conclusion: in children incidences of PR increases with the age, it was slightly higher in males and was more common during summer season. PR was found to be more commonly associated with upper respiratory tract infections in children as compared to adults, however disease was found to run a similar course as in adults.
Downloads
References
2. Bjornberg A, Tegner E. Pityriasis Rosea, In:Fitzpatrick TB, Freedberg IM, Eisen AZ, et al , eds.Dermatology in General Medicine. 5th ed. New York:McGraw Hill, 1999; 541-6.
3. Egwin AS, Martis J, Bhat RM, Kamath GH, Nanda KB. A clinical study on pityriasis rosea. Indian J Dermatol 2005;50(3):136-8.
4. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol. 1982 Jul;7(1):80-9.
5. Gilbert CM. Traite Pratique des Maladies de la Peauet de la Syphilis. 3 rd ed. Paris:1860; 402.
6. Olumide Y. Pityriasis rosea in Lagos. Int J Dermatol. 1987 May;26(4):234-6.
7. Cohen EL. Pityriasis rosea. Br J Dermatol. 1967 Oct;79(10):533-7.
8. Burch PR, Rowell NR. Pityriasis rosea--an autoaggressive disease? Statistical studies in relation to aethiology and pathogenesis. Br J Dermatol. 1970 Jun;82(6):549-60.
9. Highest AS, Kurtz J. Pityriasis rosea. In Champion RH. Burton JI, Ebling FJG (eds), Textbook of dermatology. 5thedn., Vol.2. Oxford: Blackwell Scientific Publications, 1992:948.
10. Ganguly S. A clinicoepidemiological study of pityriasis rosea in South India. Skinmed. 2013 May-Jun;11(3):141-6.
11. Gelmetti C, Rigoni C, Alessi E et al. Pityriasis lichenoides in children: clinicopathologic review of 22 cases. Pediatr Dermatol 1998;15(1):1–6.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug
reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239- 45.
13. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978.J Am Acad Dermatol. 1982 Jul;7(1):80-9.
14. BJORNBERG A, HELLGREN L. Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls. Acta Derm
Venereol Suppl (Stockh). 1962;42(Suppl 50):1-68.
15. Jacyk WK. Pityriasis rosea in Nigerians. Int J Dermatol. 1980 Sep;19(7):397-9.
16. Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009 Aug;61(2):303-18. doi: 10.1016/j.jaad.2008.07.045.
17. Drago F, Ciccarese G, Broccolo F, CozzaniE, Parodi A. Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations.Dermatology. 2015;231(1):9-14. doi:10.1159/000381285. Epub 2015 May 12.
18. Neoh CY, Tan AW, Mohamed K, Sun YJ, Tan SH.Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of
pityriasis rosea. Clin Exp Dermatol. 2010 Apr;35(3):300-4. doi: 10.1111/j.1365- 2230.2009.03469.x. Epub 2009 Jul 29.
19. Vidimos AT, Camisa C. Tongue and cheek: oral lesions in pityriasis rosea. Cutis. 1992 Oct;50(4):276-80.
20. Ahmed AA. Pityriasis rosea in Sudan. Int JDermatol.1986;25(3):184–5.DOI: 10.1111/j.1365-
4362.1986.tb02214.x.
21. Mandal SB, Dutta AK. A clinical study of pityriasis rosea. Indian J Dermatol. 1972 Jul;17(4):100-5.
22. Harman M, Aytekin S, Akdeniz S, Inalöz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol. 1998 Jul;14(5):495-7.
23. Imamura S, Ozaki M, Oguchi M, Okamoto H, Horiguchi Y. Atypical pityriasis rosea. Dermatologica. 1985;171(6):474-7.
24. Truhan AP. Pityriasis rosea. Am Fam Physician. 1984 May;29(5):193-6.
25. Watanabe T, Kawamura T, Jacob SE, Aquilino EA, Orenstein JM, Black JB et al. Pityriasis rosea isassociated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002;119(4):793–7. DOI: 10.1046/j.1523-1747.2002.00200.x.